NASDAQ:BCAB BioAtla (BCAB) News Today $1.51 -0.12 (-7.36%) (As of 10/3/2023 ET) Add Compare Share Share Today's Range$1.50▼$1.6650-Day Range$1.51▼$3.0052-Week Range$1.50▼$11.73Volume246,059 shsAverage Volume512,721 shsMarket Capitalization$72.18 millionP/E RatioN/ADividend YieldN/APrice Target$14.83 HeadlinesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBioAtla (NASDAQ:BCAB) Given New $14.00 Price Target at JPMorgan Chase & Co.americanbankingnews.com - September 26 at 2:46 AMAnalyst Ratings for BioAtlamarkets.businessinsider.com - September 25 at 3:27 PMBioAtla, Inc. (NASDAQ:BCAB) Given Consensus Rating of "Moderate Buy" by Brokeragesamericanbankingnews.com - September 25 at 4:20 AMMYDA Advisors LLC Takes $147,000 Position in BioAtla, Inc. (NASDAQ:BCAB)marketbeat.com - September 10 at 5:22 AMBioAtla to Participate in the H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - September 6 at 7:29 PMBioAtla, Inc. (NASDAQ:BCAB) Receives Consensus Recommendation of "Moderate Buy" from Analystsmarketbeat.com - August 31 at 3:20 AMConnor Clark & Lunn Investment Management Ltd. Acquires Shares of 48,614 BioAtla, Inc. (NASDAQ:BCAB)marketbeat.com - August 29 at 4:49 AMQ3 2023 EPS Estimates for BioAtla, Inc. (NASDAQ:BCAB) Lowered by Analystmarketbeat.com - August 4 at 9:49 AMBioAtla to Participate in Upcoming Investor Conferences in Augustfinance.yahoo.com - August 3 at 8:18 PMAnalysts Offer Insights on Healthcare Companies: BioAtla (BCAB), Exelixis (EXEL) and Steris (STE)markets.businessinsider.com - August 3 at 10:16 AMJP Morgan Maintains BioAtla (BCAB) Overweight Recommendationmsn.com - August 3 at 10:16 AMJMP Securities Reiterates BioAtla (BCAB) Market Outperform Recommendationmsn.com - August 3 at 10:16 AMBioAtla, Inc. (NASDAQ:BCAB) Q2 2023 Earnings Call Transcriptfinance.yahoo.com - August 3 at 10:16 AMH.C. Wainwright Reaffirms Their Buy Rating on BioAtla (BCAB)markets.businessinsider.com - August 2 at 8:51 AMBioAtla Reports Second Quarter 2023 Financial Results and Highlights Recent Progressfinance.yahoo.com - August 1 at 5:48 PMBioAtla (BCAB) Scheduled to Post Earnings on Tuesdaymarketbeat.com - July 26 at 5:12 PMBioAtla to Announce Second Quarter 2023 Financial Results and Provide Business Highlights on August 1, 2023finance.yahoo.com - July 25 at 12:14 PMBioAtla, Inc. (NASDAQ:BCAB) Given Average Rating of "Moderate Buy" by Brokeragesmarketbeat.com - July 12 at 4:11 AMWith 51% ownership of the shares, BioAtla, Inc. (NASDAQ:BCAB) is heavily dominated by institutional ownersfinance.yahoo.com - July 7 at 7:35 AMBioAtla (BCAB) Price Target Increased by 9.33% to 16.73msn.com - July 6 at 8:45 PMBioAtla, Inc. (NASDAQ:BCAB) Holdings Boosted by Vontobel Holding Ltd.marketbeat.com - June 28 at 4:43 AMBioAtla Added to Membership of U.S. Small-Cap Russell 2000® Indexfinance.yahoo.com - June 26 at 8:16 AMEndurant Capital Management LP Makes New Investment in BioAtla, Inc. (NASDAQ:BCAB)marketbeat.com - June 14 at 12:07 PMCitigroup Inc. Boosts Position in BioAtla, Inc. (NASDAQ:BCAB)marketbeat.com - June 8 at 4:30 AMBioAtla to Participate in the Jefferies Healthcare Conferencefinance.yahoo.com - May 31 at 8:20 AMOpaleye Management Inc. Invests $2.16 Million in BioAtla, Inc. (NASDAQ:BCAB)marketbeat.com - May 26 at 2:50 PMBioAtla, Inc. (NASDAQ:BCAB) Given Consensus Recommendation of "Moderate Buy" by Brokeragesmarketbeat.com - May 23 at 4:12 AMBrokers Issue Forecasts for BioAtla, Inc.'s Q2 2023 Earnings (NASDAQ:BCAB)marketbeat.com - May 17 at 6:47 AMJMP Securities Reiterates BioAtla (BCAB) Outperform Recommendationmsn.com - May 16 at 5:08 PMWhere BioAtla Stands With Analystsmarkets.businessinsider.com - May 15 at 12:48 PMHC Wainwright & Co. Reiterates BioAtla (BCAB) Buy Recommendationmsn.com - May 15 at 12:48 PMH.C. Wainwright Keeps Their Buy Rating on BioAtla (BCAB)markets.businessinsider.com - May 15 at 7:47 AMBioAtla (BCAB) Receives a Buy from JMP Securitiesmarkets.businessinsider.com - May 15 at 2:30 AMEF Hutton Reiterates BioAtla (BCAB) Buy Recommendationmsn.com - May 13 at 5:37 PMBioAtla (BCAB) Receives a Buy from BTIGmarkets.businessinsider.com - May 12 at 8:52 AMBioAtla Reports First Quarter 2023 Financial Results and Highlights Recent Progressfinance.yahoo.com - May 11 at 10:44 PMBioatla (BCAB) Earnings Dates & Reportsinvesting.com - May 11 at 12:43 PMBioAtla to Participate in the JMP Securities Life Sciences Conferencefinance.yahoo.com - May 8 at 6:11 PMBioAtla to Announce First Quarter 2023 Financial Results and Provide Business Highlights on May 11, 2023finance.yahoo.com - May 4 at 8:52 AMWe Think BioAtla (NASDAQ:BCAB) Needs To Drive Business Growth Carefullyfinance.yahoo.com - April 29 at 2:09 PMEF Hutton Maintains BioAtla (BCAB) Buy Recommendationmsn.com - April 19 at 7:40 AMBioAtla, Inc. (NASDAQ:BCAB) Q4 2022 Earnings Call Transcriptfinance.yahoo.com - March 27 at 7:39 AMJMP Securities Keeps Their Buy Rating on BioAtla (BCAB)markets.businessinsider.com - March 27 at 1:59 AMBioAtla to Announce Fourth Quarter and Full-Year 2022 Financial Results and Provide Business Highlightsfinance.yahoo.com - March 16 at 12:55 PM795,000 Shares in BioAtla, Inc. (NASDAQ:BCAB) Bought by Eventide Asset Management LLCmarketbeat.com - March 3 at 11:02 AMBioAtla Announces Change in Executive Leadershipfinance.yahoo.com - February 27 at 9:38 AMBioAtla Announces FDA Clearance of Investigational New Drug Application for BA3182, a CAB-EpCAMxCAB-CD3 Bispecific T-Cell Engager for the Treatment of Advanced Adenocarcinomafinance.yahoo.com - February 23 at 1:36 PMMassachusetts Financial Services Co. MA Grows Position in BioAtla, Inc. (NASDAQ:BCAB)marketbeat.com - February 15 at 5:15 AMRecent uptick might appease BioAtla, Inc. (NASDAQ:BCAB) institutional owners after losing 56% over the past yearfinance.yahoo.com - January 25 at 8:21 AMBioAtla (NASDAQ:BCAB) Earns Buy Rating from Analysts at EF Hutton Acquisition Co. Imarketbeat.com - January 5 at 8:39 AM Get BioAtla News Delivered to You Automatically Sign up to receive the latest news and ratings for BCAB and its competitors with MarketBeat's FREE daily newsletter. Email Address BCAB Media Mentions By Week BCAB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BCAB News Sentiment▼0.940.70▲Average Medical News Sentiment BCAB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BCAB Articles This Week▼01▲BCAB Articles Average Week Get BioAtla News Delivered to You Automatically Sign up to receive the latest news and ratings for BCAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CGEN News TSBX News CDTX News CLLS News LIFE News NSTG News JSPR News CCCC News ATHA News CRDF News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:BCAB) was last updated on 10/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioAtla, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.